Kazuya Nagao1, Tomohiko Taniguchi2, Takeshi Morimoto3, Hiroki Shiomi2, Kenji Ando4, Norio Kanamori5, Koichiro Murata6, Takeshi Kitai7, Yuichi Kawase8, Chisato Izumi9, Makoto Miyake9, Hirokazu Mitsuoka10, Masashi Kato11, Yutaka Hirano12, Shintaro Matsuda2, Tsukasa Inada1, Tomoyuki Murakami13, Yasuyo Takeuchi14, Keiichiro Yamane15, Mamoru Toyofuku16, Mitsuru Ishii17, Eri Minamino-Muta18, Takao Kato18, Moriaki Inoko18, Tomoyuki Ikeda19, Akihiro Komasa20, Katsuhisa Ishii20, Kozo Hotta21, Nobuya Higashitani22, Yoshihiro Kato23, Yasutaka Inuzuka24, Chiyo Maeda25, Toshikazu Jinnai22, Yuko Morikami26, Naritatsu Saito2, Kenji Minatoya27, Takeshi Kimura2. 1. Department of Cardiovascular Center, Osaka Red Cross Hospital. 2. Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine. 3. Department of Clinical Epidemiology, Hyogo College of Medicine. 4. Department of Cardiology, Kokura Memorial Hospital. 5. Division of Cardiology, Shimada Municipal Hospital. 6. Department of Cardiology, Shizuoka City Shizuoka Hospital. 7. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital. 8. Department of Cardiovascular Medicine, Kurashiki Central Hospital. 9. Department of Cardiology, Tenri Hospital. 10. Division of Cardiology, Nara Hospital, Kinki University Faculty of Medicine. 11. Department of Cardiology, Mitsubishi Kyoto Hospital. 12. Department of Cardiology, Kinki University Hospital. 13. Department of Cardiology, Koto Memorial Hospital. 14. Department of Cardiology, Shizuoka General Hospital. 15. Department of Cardiology, Nishikobe Medical Center. 16. Department of Cardiology, Japanese Red Cross Wakayama Medical Center. 17. Department of Cardiology, National Hospital Organization Kyoto Medical Center. 18. Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital. 19. Department of Cardiology, Hikone Municipal Hospital. 20. Department of Cardiology, Kansai Electric Power Hospital. 21. Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center. 22. Department of Cardiology, Japanese Red Cross Otsu Hospital. 23. Department of Cardiology, Saiseikai Noe Hospital. 24. Department of Cardiology, Shiga Medical Center for Adults. 25. Department of Cardiology, Hamamatsu Rosai Hospital. 26. Department of Cardiology, Hirakata Kohsai Hospital. 27. Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine.
Abstract
BACKGROUND: Clinical profiles of acute heart failure (AHF) complicating severe aortic stenosis (AS) remain unclear.Methods and Results: From a Japanese multicenter registry enrolling consecutive patients with severe AS, 3,813 patients were categorized into the 3 groups according to the symptom of heart failure (HF); No HF (n=2,210), chronic HF (CHF) (n=813) and AHF defined as hospitalized HF at enrolment (n=790). Median follow-up was 1,123 days with 93% follow-up rate at 2 years. Risk factors for developing AHF included age, female sex, lower body mass index, untreated coronary artery stenosis, anemia, history of HF, left ventricular ejection fraction <50%, presence of any combined valvular disease, peak aortic jet velocity ≥5 m/s and tricuspid regurgitation pressure gradient ≥40 mmHg, and negative risk factors included dyslipidemia, history of percutaneous coronary intervention and hemodialysis. Respective cumulative 5-year incidences of all-cause death and HF hospitalization in No HF, CHF and AHF groups were 37.1%, 41.8% and 61.8% (P<0.001) and 20.7%, 33.8% and 52.3% (P<0.001). Even in the initial aortic valve replacement (AVR) stratum, AHF was associated with excess 5-year mortality risk relative to No HF and CHF (adjusted hazard ratio [HR] 1.64; 95% confidence interval [CI]: 1.14-2.36, P=0.008; adjusted HR 1.47; 95% CI: 1.03-2.11, P=0.03, respectively). CONCLUSIONS: AHF complicating severe AS was associated with an extremely dismal prognosis, which could not be fully resolved by AVR. Careful management to avoid the development of AHF is crucial.
BACKGROUND: Clinical profiles of acute heart failure (AHF) complicating severe aortic stenosis (AS) remain unclear.Methods and Results: From a Japanese multicenter registry enrolling consecutive patients with severe AS, 3,813 patients were categorized into the 3 groups according to the symptom of heart failure (HF); No HF (n=2,210), chronic HF (CHF) (n=813) and AHF defined as hospitalized HF at enrolment (n=790). Median follow-up was 1,123 days with 93% follow-up rate at 2 years. Risk factors for developing AHF included age, female sex, lower body mass index, untreated coronary artery stenosis, anemia, history of HF, left ventricular ejection fraction <50%, presence of any combined valvular disease, peak aortic jet velocity ≥5 m/s and tricuspid regurgitation pressure gradient ≥40 mmHg, and negative risk factors included dyslipidemia, history of percutaneous coronary intervention and hemodialysis. Respective cumulative 5-year incidences of all-cause death and HF hospitalization in No HF, CHF and AHF groups were 37.1%, 41.8% and 61.8% (P<0.001) and 20.7%, 33.8% and 52.3% (P<0.001). Even in the initial aortic valve replacement (AVR) stratum, AHF was associated with excess 5-year mortality risk relative to No HF and CHF (adjusted hazard ratio [HR] 1.64; 95% confidence interval [CI]: 1.14-2.36, P=0.008; adjusted HR 1.47; 95% CI: 1.03-2.11, P=0.03, respectively). CONCLUSIONS: AHF complicating severe AS was associated with an extremely dismal prognosis, which could not be fully resolved by AVR. Careful management to avoid the development of AHF is crucial.
Authors: Hans Huang; Christopher P Kovach; Sean Bell; Mark Reisman; Gabriel Aldea; James M McCabe; Danny Dvir; Creighton Don Journal: J Interv Cardiol Date: 2019-11-03 Impact factor: 2.279
Authors: Russell J Everett; Thomas A Treibel; Miho Fukui; Heesun Lee; Marzia Rigolli; Anvesha Singh; Petra Bijsterveld; Lionel Tastet; Tarique Al Musa; Laura Dobson; Calvin Chin; Gabriella Captur; Sang Yong Om; Stephanie Wiesemann; Vanessa M Ferreira; Stefan K Piechnik; Jeanette Schulz-Menger; Erik B Schelbert; Marie-Annick Clavel; David E Newby; Saul G Myerson; Phillipe Pibarot; Sahmin Lee; João L Cavalcante; Seung-Pyo Lee; Gerry P McCann; John P Greenwood; James C Moon; Marc R Dweck Journal: J Am Coll Cardiol Date: 2020-01-28 Impact factor: 24.094